Results 71 to 80 of about 11,553 (254)

Timing of Surgery under Mechanical Circulatory Support for Ventricular Septal Rupture Due to Acute Myocardial Infarction [PDF]

open access: yes, 2022
The optimal timing of acute myocardial infarction-associated ventricular septal rupture surgery is controversial. Therefore, we examined the appropriateness of our ventricular septal rupture surgical strategy for early surgery in absence of organ failure
Fukuda, Hirotsugu   +10 more
core   +1 more source

Impella CP-assisted balloon aortic valvuloplasty [PDF]

open access: yesJournal of Cardiology Cases, 2016
Percutaneous ventricular assist device (PVAD) use in balloon aortic valvuloplasty (BAV) has been performed sporadically. The PVAD used was TandemHeart. A few cases were reported using Impella 2.5 device. We report the first case of Impella CP-assisted BAV. The use of PVAD has been contraindicated in severe aortic stenosis (AS).
Michael, Megaly, Paul, Jones
openaire   +2 more sources

Lethal Case of Bourbon Virus Leading to Shock and ECMO Utilization

open access: yesCase Reports in Infectious Diseases, Volume 2026, Issue 1, 2026.
We present a lethal case of Bourbon virus infection in a 63‐year‐old Caucasian, diabetic male who was previously in good health. The patient had spent time in the wooded areas of Bourbon County, Kansas, and removed three ticks from his body 5 days prior to presentation.
Allianna Mitchell   +7 more
wiley   +1 more source

Impella Versus Intra‐Aortic Balloon Pump in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: An Observational Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Venoarterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly used for patients with cardiogenic shock. Although Impella or intra‐aortic balloon pump (IABP) is frequently used for left ventricular unloading (LVU) during VA‐ECMO ...
Ilhwan Yeo   +12 more
doaj   +1 more source

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock

open access: yesJournal of Cardiothoracic Surgery, 2020
Background Acute cardiogenic shock is associated with high mortality rates. The Impella device is a microaxial left ventricular assist device that can be inserted through the axillary artery.
Saeed Tarabichi   +4 more
doaj   +1 more source

Outcomes of Impella compared with intra-aortic balloon pump in ST-elevation myocardial infarction complicated by cardiogenic shock

open access: yesAmerican Heart Journal Plus, 2021
Background: Despite limited randomized trial data demonstrating clinical efficacy, the utilization of Impella in ST-elevation myocardial infarction (STEMI) patients complicated with cardiogenic shock (CS) has increased over time.
Samarthkumar Thakkar   +16 more
doaj   +1 more source

Safety and Feasibility of Impella CP Decannulation With a Preclosure Technique in Myocardial Infarction With Cardiogenic Shock

open access: yesJournal of Interventional Cardiology, Volume 2026, Issue 1, 2026.
Background The Impella CP is a widely used mechanical circulatory support device for patients with cardiogenic shock undergoing high‐risk percutaneous coronary intervention. Hemostasis following Impella removal remains a clinical challenge. Although the preclosure technique using the Perclose ProGlide device is standard in elective procedures, its ...
Kosuke Muto   +4 more
wiley   +1 more source

Lower extremity artery thromboembolism during removal of Impella after repair for ventricular septal rupture: A case report

open access: yesSAGE Open Medical Case Reports
Although the anticoagulant complications of Impella are well known, the timing of heparin administration when using Impella immediately after open heart surgery has not been established.
Yoshifumi Itoda   +9 more
doaj   +1 more source

Computational Evaluation of IABP, Impella 2.5, TandemHeart and Combined IABP and Impella 2.5 Support in Cardiogenic Shock

open access: yesMathematics, 2023
Cardiogenic shock is a life-threatening condition consisting of low cardiac output status leading to end-organ hypoperfusion following either acute left or right ventricular failure or decompensation of chronic heart failure.
Rahmi Alkan   +4 more
doaj   +1 more source

Central extracorporeal life support with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure [PDF]

open access: yes, 2014
BACKGROUND: The purpose of this prospective study was to evaluate the effects and functional outcome of central extracorporeal life support (ECLS) with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure ...
Alexander Weymann   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy